A 62-year-old male smoker with a 40 pack-year history presents with progressive dyspnea, chronic cough, and sputum production for the past 3 years. Spirometry shows FEV₁/FVC ratio of 0.58 with FEV₁ 45% predicted. Chest X-ray reveals hyperinflation with flattened diaphragms and a prominent vascular pattern in the lower lung zones. He denies acute exacerbation symptoms. What is the most appropriate next step in management?

Explanation

## Clinical Assessment This patient presents with **COPD GOLD Stage 2 (moderate airflow obstruction)** based on spirometry (FEV₁ 40–59% predicted). He is **stable** (no acute exacerbation) and requires **maintenance pharmacotherapy** rather than diagnostic or surgical intervention. ## Management Algorithm for Stable COPD ```mermaid flowchart TD A[COPD diagnosis confirmed]:::outcome --> B{Exacerbation?}:::decision B -->|Yes| C[Acute management]:::action B -->|No| D{GOLD Group?}:::decision D -->|Group A: FEV₁ ≥50%| E[SABA or SAMA]:::action D -->|Group B: FEV₁ 30-49%| F[LABA ± LAMA]:::action D -->|Group C: High exacerbation| G[ICS-LABA or LAMA]:::action F --> H[Reassess at 4-6 weeks]:::action ``` ## Key Point: **Maintenance therapy for stable COPD Stage 2 (FEV₁ 40–59%)** begins with **LABA/LAMA combination** (e.g., tiotropium + formoterol). This is guideline-standard and improves symptoms and exacerbation rates [cite:Harrison 21e Ch 297]. ## High-Yield: - **FEV₁/FVC < 0.70** = airflow obstruction (COPD confirmed) - **FEV₁ 40–59%** = GOLD Stage 2 (moderate) - **Stable state** = no acute exacerbation → maintenance therapy, not acute interventions ## Clinical Pearl: The **prominent vascular pattern in lower zones** (not upper lobe bullae) and **flattened diaphragms** suggest **chronic bronchitis phenotype with emphysema**, not pure emphysema. LABA/LAMA is appropriate for both phenotypes in this stage. ## Why Not the Others? | Option | Why Incorrect | |--------|---------------| | HRCT chest | Diagnostic imaging is useful for phenotyping or ruling out bronchiectasis, but **not the next step in a stable patient with confirmed COPD**. Imaging does not change immediate management. | | Lung volume reduction surgery | **Requires** FEV₁ < 25% predicted, upper lobe emphysema on imaging, and failed optimal medical therapy. This patient is Stage 2 with moderate obstruction — **premature for surgical referral**. | | Empirical antibiotics | **No indication** in stable COPD without acute exacerbation. Chronic antibiotic use increases resistance and is not guideline-recommended. |